🇺🇸 FDA
Patent

US 7479484

Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

granted A61KA61K38/10A61P

Quick answer

US patent 7479484 (Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity) held by Takeda Pharmaceutical Company Limited expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/10, A61P, A61P11/06, A61P19/02